189 related articles for article (PubMed ID: 31054097)
1. Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature.
Nguyen TK; Perry J; Sundaram ANE; Detsky J; Maralani PJ; Calabrese E; Das S; Sahgal A
J Neurooncol; 2019 Jul; 143(3):475-481. PubMed ID: 31054097
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases.
Miyatake S; Furuse M; Kawabata S; Maruyama T; Kumabe T; Kuroiwa T; Ono K
Neuro Oncol; 2013 Jun; 15(6):650-5. PubMed ID: 23460324
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.
Foster KA; Ares WJ; Pollack IF; Jakacki RI
Pediatr Blood Cancer; 2015 Feb; 62(2):240-245. PubMed ID: 25382690
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
Lubelski D; Abdullah KG; Weil RJ; Marko NF
J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
[TBL] [Abstract][Full Text] [Related]
6. Single-shot bevacizumab for cerebral radiation injury.
Voss M; Wenger KJ; Fokas E; Forster MT; Steinbach JP; Ronellenfitsch MW
BMC Neurol; 2021 Feb; 21(1):77. PubMed ID: 33596839
[TBL] [Abstract][Full Text] [Related]
7. Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.
van West SE; de Bruin HG; van de Langerijt B; Swaak-Kragten AT; van den Bent MJ; Taal W
Neuro Oncol; 2017 May; 19(5):719-725. PubMed ID: 28453748
[TBL] [Abstract][Full Text] [Related]
8. Severe Radiation Necrosis Successfully Treated With Bevacizumab in an Infant with Low-Grade Glioma and Tumor-Associated Intractable Trigeminal Neuralgia.
Pillay Smiley N; Alden T; Hartsell W; Fangusaro J
Pediatr Blood Cancer; 2016 Sep; 63(9):1671-3. PubMed ID: 27187113
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
Khan M; Zhao Z; Arooj S; Liao G
BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy.
Ludmir EB; Mahajan A; Paulino AC; Jones JY; Ketonen LM; Su JM; Grosshans DR; McAleer MF; McGovern SL; Lassen-Ramshad YA; Adesina AM; Dauser RC; Weinberg JS; Chintagumpala MM
Neuro Oncol; 2019 May; 21(5):686-695. PubMed ID: 30753704
[TBL] [Abstract][Full Text] [Related]
11. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?
Forsyth PA; Kelly PJ; Cascino TL; Scheithauer BW; Shaw EG; Dinapoli RP; Atkinson EJ
J Neurosurg; 1995 Mar; 82(3):436-44. PubMed ID: 7861222
[TBL] [Abstract][Full Text] [Related]
12. Pseudoprogression of low-grade gliomas after radiotherapy.
Naftel RP; Pollack IF; Zuccoli G; Deutsch M; Jakacki RI
Pediatr Blood Cancer; 2015 Jan; 62(1):35-9. PubMed ID: 25213668
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
[TBL] [Abstract][Full Text] [Related]
14. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
[TBL] [Abstract][Full Text] [Related]
15. Pseudoprogression after glioma therapy: a comprehensive review.
Kruser TJ; Mehta MP; Robins HI
Expert Rev Neurother; 2013 Apr; 13(4):389-403. PubMed ID: 23545054
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
Indelicato DJ; Rotondo RL; Uezono H; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Bradley JA
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):149-156. PubMed ID: 30684665
[TBL] [Abstract][Full Text] [Related]
17. An analysis of radiation necrosis of the central nervous system treated with bevacizumab.
Tye K; Engelhard HH; Slavin KV; Nicholas MK; Chmura SJ; Kwok Y; Ho DS; Weichselbaum RR; Koshy M
J Neurooncol; 2014 Apr; 117(2):321-7. PubMed ID: 24504500
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas.
Furuse M; Nonoguchi N; Kawabata S; Miyata T; Toho T; Kuroiwa T; Miyatake S
Radiat Oncol; 2015 Jul; 10():156. PubMed ID: 26223253
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
Matuschek C; Bölke E; Nawatny J; Hoffmann TK; Peiper M; Orth K; Gerber PA; Rusnak E; Lammering G; Budach W
Strahlenther Onkol; 2011 Feb; 187(2):135-9. PubMed ID: 21336713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
